SCHEMBL5731978

SCHEMBL5731978

COc1ccc(Cn2c(O)nc3c(N)nc(C)nc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.47
▸ ALDH1A1 P00352 6/20 0.47
▸ GLA P06280 4/20 0.47
▸ GAA P10253 4/20 0.47
▸ HPGD P15428 4/20 0.47
▸ CASP1 P29466 3/20 0.47
▸ CASP7 P55210 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ USP2 O75604 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ PDE8B O95263 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ DCTPP1 Q9H773 2/20 0.43
▸ TLR7 Q9NYK1 6/20 0.43
▸ PNP P00491 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5731691 0.87 TLR7 (0.43) KDM4EALDH1A1HPGDHSD17B10TLR7
SCHEMBL5730974 0.87 TLR7 (0.43) KDM4EALDH1A1GAAHPGDNPSR1
SCHEMBL5731373 0.86 TLR7 (0.42) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL5730944 0.84 TLR7 (0.55) KDM4EALDH1A1GAAHPGDCASP1
SCHEMBL5731860 0.83 TLR7 (0.43) KMT2ATLR7
SCHEMBL5731748 0.82 CCR9 (0.42) KMT2ATLR7SMN1; SMN2TP53
SCHEMBL10309737 0.81 TLR7 (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL5731246 0.81 FBP1 (0.44) ALDH1A1KMT2ATLR7SMN1; SMN2
SCHEMBL10309731 0.80 KDM4E (0.39) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL5731513 0.80 L3MBTL1 (0.50) KDM4ENPSR1MAPK1KMT2ATLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1043021-B1 PURINE DERIVATIVES FOR THE TREATMENT OF ALLERGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS DAINIPPON SUMITOMO PHARMA CO (JP) 2006-05-03 — — EP disclosed
EP-0882727-B9 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2005-06-15 — — EP disclosed
EP-0882727-B1 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2004-12-01 — — EP disclosed
US-6376501-B1 INHIBITING OR REGULATING IMMUNE RESPONSE USING PURINE-DERIVED COMPOUND; NON-STEROIDAL COMPOUND JAPAN ENERGY CORPORATION (JP) 2002-04-23 — — US disclosed
EP-1043021-A1 TYPE 2 HELPER T CELL-SELECTIVE IMMUNE RESPONSE SUPPRESSORS Japan Energy Corporation (JP) 2000-10-11 — — EP disclosed
US-6028076-A FOR INDUCING .ALPHA.-INTERFERON IN A PATIENT HAVING HEPATITIS B OR C, BY ADMINISTERING PURINE DERIVATIVE JAPAN ENERGY CORPORATION (JP) 2000-02-22 — — US disclosed
EP-0882727-A1 NOVEL PURINE DERIVATIVES JAPAN ENERGY CORPORATION (JP) 1998-12-09 — — EP disclosed
Send feedback